The significance of SMARCB1 in the pathogenesis of renal cell carcinoma with rhabdoid features

CONCLUSION: Inactivation of INI1 may play a role in the pathogenesis of RCC-RF. Erlotinib is recommended in the management of patients with INI1-related RCC.PMID:34243015 | DOI:10.1016/j.tranon.2021.101175
Source: Translational Oncology - Category: Cancer & Oncology Authors: Source Type: research